Browsed by
Tag: policy

A farewell to the ASBMB ?>

A farewell to the ASBMB

Today I bid farewell to the American Society for Biochemistry and Molecular Biology. After three and a half years at the ASBMB, I will start in a new position next week as the director of Rescuing Biomedical Research. I have enjoyed my time at the ASBMB mostly because I have been able to work on, and make significant contributions to, the issues that matter most to me. As a postdoctoral scholar, I was drawn to science policy by the deficiencies…

Read More Read More

The ASBMB Sustainability Summit ?>

The ASBMB Sustainability Summit

Training periods and trainee populations have increased over the past decade despite stagnant federal funding, resulting in a research workforce that is expanding beyond the capacity of the available funding to support it. A variety of groups have written reports describing these problems in great detail and made a series of recommendations to fix them. The Public Affairs Advisory Committee of the American Society for Biochemistry and Molecular Biology has also been working on issues concerning the sustainability of the…

Read More Read More

Winners announced from ASBMB / FOR joint Hack Day ?>

Winners announced from ASBMB / FOR joint Hack Day

This post was written by Gary McDowell, Cara Weismann and Chris Pickett. The Boston Future of Research recently held its second symposium focusing on data collection and transparency regarding career opportunities in the scientific enterprise. The discussion covered the data that should be collected, by whom and for what purpose. The conversations also touched on the size, structure and composition of the research workforce and barriers to reform. On Oct. 24, the American Society for Biochemistry and Molecular Biology in…

Read More Read More

Announcing the ASBMB/FOR Hack Day on Oct. 24 ?>

Announcing the ASBMB/FOR Hack Day on Oct. 24

The American Society for Biochemistry and Molecular Biology is pleased to announce a partnership with the Boston Future of Research to jointly host a Hack Day on Saturday, Oct. 24 to find innovative solutions to collecting data and tracking biomedical scientists throughout their careers. Graduate student and postdoc populations have increased significantly over the past several decades. However, the size and structure of the trainee population is not known. Furthermore, unemployment among biomedical Ph.D.s is below that of the general…

Read More Read More

A Strategic Plan for the NIH ?>

A Strategic Plan for the NIH

The fiscal 2015 spending package that became law carried a provision directing the National Institutes of Health to develop its first strategic plan. Lawrence Tabak, principle deputy director of the NIH, presented the current framework of the strategic plan at a meeting of the Advisory Council to the Director last week. This was followed by the release of a request for information asking for input from the scientific community on the agency-wide strategic plan. The strategic plan will examine NIH…

Read More Read More

Toward a sustainable biomedical research enterprise: More work required ?>

Toward a sustainable biomedical research enterprise: More work required

On Monday, members of the American Society for Biochemistry and Molecular Biology published a Perspective in the Proceedings of the National Academy of Sciences. “Toward a sustainable biomedical research enterprise: Finding consensus and implementing recommendations” describes eight recommendations addressing some of the most pressing problems faced by the enterprise. Today’s post will discuss the ASBMB’s next steps toward sustainability. Monday’s post focused on an author’s perspective of this paper. Tuesday’s post discussed the coordinated implementation of recommendations. Implementing consensus recommendations…

Read More Read More

Toward a sustainable biomedical research enterprise: Coordinated implementation of recommendations ?>

Toward a sustainable biomedical research enterprise: Coordinated implementation of recommendations

Yesterday, members of the American Society for Biochemistry and Molecular Biology published a Perspective in the Proceedings of the National Academy of Sciences. “Toward a sustainable biomedical research enterprise: Finding consensus and implementing recommendations” describes eight recommendations addressing some of the most pressing problems faced by the enterprise. Today’s post will focus on coordinated implementation of recommendations. Monday’s post focused on an author’s perspective of this paper. Wednesday’s post will discuss the next steps in this process.

Toward a sustainable biomedical research enterprise: An author’s perspective ?>

Toward a sustainable biomedical research enterprise: An author’s perspective

Today, members of the American Society for Biochemistry and Molecular Biology published a Perspective in the Proceedings of the National Academy of Sciences. “Toward a sustainable biomedical research enterprise: Finding consensus and implementing recommendations” describes eight recommendations addressing some of the most pressing problems faced by the enterprise. This post is a synopsis of what led us to write the paper. Tuesday’s post will focus on coordinated implementation of recommendations. Wednesday’s post will discuss the next steps in this process.

Research reproducibility rises to the top ?>

Research reproducibility rises to the top

The National Institutes of Health and a highly publicized perspective recently focused the attention of the biomedical research community on reproducibility and rigor. The NIH has been working on reproducibility and rigor for several years since the publication of reports from industry leaders claiming most preclinical research was irreproducible. While NIH policies on research reproducibility have been expected for some time, the new sensational paper in PLoS Biology purporting to quantify the money spent on irreproducible research has brought the…

Read More Read More

21st Century Cures Act passes committee ?>

21st Century Cures Act passes committee

Today, the U.S. House Energy and Commerce committee voted unanimously in favor of the 21st Century Cures Act, formally known as H.R. 6. Work on this legislation began over a year ago with the goal of speeding discovery, development and delivery of therapies and cures to patients. Should H.R. 6 become law, it would make important changes to the National Institutes of Health, the Food and Drug Administration and other federal agencies working on healthcare issues. The 21st Century Cures…

Read More Read More